Cart (0 Items)
Your cart is currently empty.
View ProductsNesvacumab Biosimilar – Anti-ANGPT2 mAb – Research Grade
| Size | |
|---|---|
| Brand | |
| Product type | |
| Clonality | |
| Expression system | |
| Applications |
| Product name | Nesvacumab Biosimilar - Anti-ANGPT2 mAb - Research Grade |
|---|---|
| Source | CAS 1296818-77-3 |
| Species | Homo sapiens |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Applications | ELISA,WB |
| Aliases /Synonyms | Nesvacumab,REGN-910,ANGPT2,anti-ANGPT2 |
| Reference | PX-TA1311 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-nd |
| Clonality | Monoclonal Antibody |
Description of Nesvacumab Biosimilar - Anti-ANGPT2 mAb - Research Grade
General information on Anti-ANGPT2[Homo sapiens] (Nesvacumab) Monoclonal Antibody
Nesvacumab is investigated for the treatment of Neovascular (Wet) Age Related Macular Degeneration (AMD) or Diabetic Macular Edema (DME).
Nesvacumab Biosimilar - Anti-ANGPT2 mAb binds to Humand ANGPT2 in indirect ELISA Assay
Immobilized Human ANGPT2-Ang2 recombinant protein (cat. No. PX-P6245) at 0.5µg/mL (100µL/well) can bind Nesvacumab Biosimilar - Anti-ANGPT2 mAb (cat. No. PX-TA1311) in indirect ELISA with Goat Anti-human IgG secondary antibody coupled with HRP measured by OD450 giving an EC50 at 16.93M.
Related products
Antigen
Human ANGPT2-Ang2 recombinant protein
PX-P6245 395€
SIL
Stable Isotope Labelled Nesvacumab Biosimilar – Anti-ANGPT2 mAb – Research Grade
PX-TA1311-SIL 15000€
ELISA
Reviews
Il n’y a pas encore d’avis.